InSightec
Tirat Carmel
About InSightec
InSightec is the pioneer and global leader in MR guided focused ultrasound technology for image guided acoustic surgery. ExAblate® 2000 system was the first system to use the MR guided focused ultrasound technology. The ExAblate system received CE mark in 2002 and the Food and Drug Administration (FDA) approval in 2004 for the treatment of symptomatic uterine fibroids. ExAblate received the European CE Mark for pain palliation of bone metastases in June 2007 and for adenomyosis in June 2010. This device has won numerous innovation awards and has been used to treat thousands of patients around the world.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 251 – 500
- Estimated revenue: $1K – $10K
- Total funding: $882.9M
- Funding stage: Private Equity
- Last round: Private Equity (Jun 2024)
- Website: insightec.com
- Phone: 1(121)463-0000
Industries & Categories
Biotechnology, Health Care, Manufacturing, Medical Device, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/insightec-95768 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.